|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111.05 EUR | +3.16% |
|
-8.49% | -9.42% |
| 03-09 | MERCK KGAA : Goldman Sachs reiterates its Buy rating | ZD |
| 03-09 | MERCK KGAA : Deutsche Bank sticks Neutral | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 54.26B | |||||
| 8.04B | |||||
| 7.29B | |||||
| 5.2B | |||||
| 4.85B | |||||
| 3.12B | - | - |
- Stock Market
- Equities
- MRK Stock
- Charts Merck KGaA
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition